BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1064 related articles for article (PubMed ID: 35755823)

  • 1. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
    Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
    Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes.
    Wang Z; Tang J; Jin E; Ren C; Li S; Zhang L; Zhong Y; Cao Y; Wang J; Zhou W; Zhao M; Huang L; Qu J
    Front Endocrinol (Lausanne); 2022; 13():986303. PubMed ID: 36157454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine and Carnitine Metabolites Are Altered in Diabetic Retinopathy.
    Sumarriva K; Uppal K; Ma C; Herren DJ; Wang Y; Chocron IM; Warden C; Mitchell SL; Burgess LG; Goodale MP; Osborn MP; Ferreira AJ; Law JC; Cherney EF; Jones DP; Brantley MA
    Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):3119-3126. PubMed ID: 31323682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azelaic acid and guanosine in tears improve discrimination of proliferative from non-proliferative diabetic retinopathy in type-2 diabetes patients: A tear metabolomics study.
    Wen X; Ng TK; Liu Q; Wu Z; Zhang G; Zhang M
    Heliyon; 2023 May; 9(5):e16109. PubMed ID: 37305454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel risk score model for non-proliferative diabetic retinopathy based on untargeted metabolomics of venous blood.
    Wang X; Yang S; Yang G; Lin J; Zhao P; Ding J; Sun H; Meng T; Yang MM; Kang L; Liang Z
    Front Endocrinol (Lausanne); 2023; 14():1180415. PubMed ID: 37670880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Analysis of Metabolomics and Lipidomics in Plasma of T2DM Patients with Diabetic Retinopathy.
    Ding C; Wang N; Wang Z; Yue W; Li B; Zeng J; Yoshida S; Yang Y; Zhou Y
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis.
    Yang QH; Zhang Y; Zhang XM; Li XR
    Int J Ophthalmol; 2019; 12(2):302-311. PubMed ID: 30809489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma metabolomic profiling of proliferative diabetic retinopathy.
    Zhu XR; Yang FY; Lu J; Zhang HR; Sun R; Zhou JB; Yang JK
    Nutr Metab (Lond); 2019; 16():37. PubMed ID: 31160916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Arginine and Citrulline are Elevated in Diabetic Retinopathy.
    Peters KS; Rivera E; Warden C; Harlow PA; Mitchell SL; Calcutt MW; Samuels DC; Brantley MA
    Am J Ophthalmol; 2022 Mar; 235():154-162. PubMed ID: 34587493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy.
    Ancel P; Martin JC; Doukbi E; Houssays M; Gascon P; Righini M; Matonti F; Svilar L; Valmori M; Tardivel C; Venteclef N; Julla JB; Gautier JF; Resseguier N; Dutour A; Gaborit B
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary serum and fecal metabolomics study of spontaneously diabetic cynomolgus monkeys based on LC-MS/MS.
    Tian C; Qiu M; Lv H; Yue F; Zhou F
    J Med Primatol; 2022 Dec; 51(6):355-366. PubMed ID: 35993379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics profiles associated with diabetic retinopathy in type 2 diabetes patients.
    Yun JH; Kim JM; Jeon HJ; Oh T; Choi HJ; Kim BJ
    PLoS One; 2020; 15(10):e0241365. PubMed ID: 33119699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics-based multidimensional network biomarkers for diabetic retinopathy identification in patients with type 2 diabetes mellitus.
    Zuo J; Lan Y; Hu H; Hou X; Li J; Wang T; Zhang H; Zhang N; Guo C; Peng F; Zhao S; Wei Y; Jia C; Zheng C; Mao G
    BMJ Open Diabetes Res Care; 2021 Feb; 9(1):. PubMed ID: 33593748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Coverage Serum Metabolomics Reveals Metabolic Pathway Dysregulation in Diabetic Retinopathy: A Propensity Score-Matched Study.
    Guo C; Jiang D; Xu Y; Peng F; Zhao S; Li H; Jin D; Xu X; Xia Z; Che M; Lai M; Huang R; Wang H; Zheng C; Mao G
    Front Mol Biosci; 2022; 9():822647. PubMed ID: 35372500
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
    Gu Y; Zang P; Li J; Yan Y; Wang J
    Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and Vitreous Metabolomics Profiling of Proliferative Diabetic Retinopathy.
    Wang H; Li S; Wang C; Wang Y; Fang J; Liu K
    Invest Ophthalmol Vis Sci; 2022 Feb; 63(2):17. PubMed ID: 35133401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short communication: unique metabolic signature of proliferative retinopathy in the tear fluid of diabetic patients with comorbidities - preliminary data for PPPM validation.
    Kropp M; De Clerck E; Vo TKS; Thumann G; Costigliola V; Golubnitschaja O
    EPMA J; 2023 Mar; 14(1):43-51. PubMed ID: 36845280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum metabolomic profiles and semaphorin-3A as biomarkers of diabetic retinopathy progression.
    Mokhtar ER; Mahmoud DA; Ebrahim GE; Al Anany MG; Seliem N; Hassan MM
    Egypt J Immunol; 2023 Apr; 30(2):83-98. PubMed ID: 37031410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
    He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
    J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untargeted metabolomics analysis of the anti-diabetic effect of Red ginseng extract in Type 2 diabetes Mellitus rats based on UHPLC-MS/MS.
    Yang Z; Dan Wang ; Li Y; Zhou X; Liu T; Shi C; Li R; Zhang Y; Zhang J; Yan J; Zhu X; Li Y; Gong M; Wang C; Yuan C; Cui Y; Wu X
    Biomed Pharmacother; 2022 Feb; 146():112495. PubMed ID: 34891123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.